• Gyre Therapeutics COO Ye Weiguo exercised stock options for 11,000 shares at $0.75 from June 9-18, 2026.
• He sold 11,000 shares over the same period at prices of $6.15, $6.24, $6.35.
• Directly held common stock ended at 700,000 shares.
• Directly held stock options ended at 827,701 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gyre Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-025950), on June 22, 2026, and is solely responsible for the information contained therein.